Verastem, Inc. Files 8-K Report
Ticker: VSTM · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1526119
| Field | Detail |
|---|---|
| Company | Verastem, INC. (VSTM) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $7, $96.9 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-event
TL;DR
Verastem filed an 8-K today, expect news soon.
AI Summary
On November 13, 2025, Verastem, Inc. filed an 8-K report. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items. The company is incorporated in Delaware and headquartered in Needham, MA.
Why It Matters
This 8-K filing signals significant corporate events or financial updates from Verastem, Inc. that could impact investors and the company's market position.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, which typically announces material events but doesn't inherently carry immediate high risk without further details on the events themselves.
Key Numbers
- 001-35403 — Commission File Number (Identifies the company's filing with the SEC.)
- 27-3269467 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Verastem, Inc. (company) — Registrant
- November 13, 2025 (date) — Date of earliest event reported
- Needham, MA (location) — Principal Executive Offices
- 02494 (postal_code) — Zip Code for Principal Executive Offices
- (781) 292-4200 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Verastem, Inc. in this 8-K filing?
The provided text for the 8-K filing lists 'Other Events' as an item information, but does not specify the nature of these events.
What are the 'Financial Statements and Exhibits' that Verastem, Inc. is reporting?
The filing indicates 'Financial Statements and Exhibits' as item information, but the specific details of these statements and exhibits are not included in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on November 13, 2025.
Where is Verastem, Inc.'s principal executive office located?
Verastem, Inc.'s principal executive office is located at 117 Kendrick Street, Suite 500, Needham, MA 02494.
What is Verastem, Inc.'s telephone number?
Verastem, Inc.'s telephone number, including area code, is (781) 292-4200.
Filing Stats: 1,343 words · 5 min read · ~4 pages · Grade level 12.6 · Accepted 2025-11-17 07:30:39
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value per share VSTM The Nasdaq
- $7 — d at an offering price to the public of $7.25, and each Pre-Funded Warrant is bein
- $96.9 m — ted offering expenses, of approximately $96.9 million, including net proceeds from the
Filing Documents
- tm2531440d1_8k.htm (8-K) — 33KB
- tm2531440d1_ex1-1.htm (EX-1.1) — 370KB
- tm2531440d1_ex4-1.htm (EX-4.1) — 71KB
- tm2531440d1_ex5-1.htm (EX-5.1) — 11KB
- tm2531440d1_ex99-1.htm (EX-99.1) — 5KB
- tm2531440d1_ex1-1img001.jpg (GRAPHIC) — 4KB
- tm2531440d1_ex4-1img01.jpg (GRAPHIC) — 9KB
- tm2531440d1_ex5-1img02.jpg (GRAPHIC) — 10KB
- tm2531440d1_ex5-1img03.jpg (GRAPHIC) — 5KB
- 0001104659-25-112946.txt ( ) — 802KB
- vstm-20251113.xsd (EX-101.SCH) — 3KB
- vstm-20251113_lab.xml (EX-101.LAB) — 33KB
- vstm-20251113_pre.xml (EX-101.PRE) — 22KB
- tm2531440d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On November 13, 2025, Verastem, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Jefferies LLC and Guggenheim Securities, LLC, as representatives of the several underwriters named in Schedule A thereto (the "Underwriters"), relating to the underwritten public offering, issuance and sale by the Company of: (i) 8,543,794 shares (the "Firm Shares") of the Company's common stock, par value $0.0001 per share (the "Common Stock"), and (ii) to certain investors, pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 3,870,000 shares of Common Stock (collectively, the "Offering"). In addition, pursuant to the Underwriting Agreement, the Company granted the Underwriters an option to purchase up to an additional 1,862,069 shares (the "Option Shares", and together with the Firm Shares, the "Shares") of Common Stock within 30 days from the date of the Underwriting Agreement. The Underwriters exercised their option to purchase the Option Shares in full on November 14, 2025. All of the Shares and the Pre-Funded Warrants will be sold by the Company. Each Share is being offered at an offering price to the public of $7.25, and each Pre-Funded Warrant is being offered an offering price to the public of $7.2499, which is equal to the offering price per Share less the $0.0001 exercise price of each Pre-Funded Warrant. The Company expects to receive net proceeds from the Offering, after deducting underwriting discounts and commissions and estimated offering expenses, of approximately $96.9 million, including net proceeds from the exercise of the Underwriters' option to purchase the Option Shares in full. The Offering was made pursuant to the Company's shelf registration statement on Form S-3 (File No. 333-275408), which was declared effective on November 20, 2023. The closing of the Offering is expected to take place on or about November 17, 2025, subject to the satisfaction of customary closing condit
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERASTEM, INC. Dated: November 17, 2025 By: /s/ Daniel W. Paterson Daniel W. Paterson President and Chief Executive Officer